Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia

Infection and Drug Resistance
Bo ZhaoRui Zheng

Abstract

To evaluate the efficacy and safety of 500 mg of nemonoxacin administered orally once daily to outpatients with community-acquired pneumonia (CAP). Patients with CAP who received nemonoxacin monotherapy were selected from outpatients who visited the Department of Pulmonary and Critical Care Medicine of Shengjing Hospital of China Medical University between July and December 2018. Their characteristics, pneumonia-related symptoms, treatment effects, and adverse reactions were recorded. In total, 337 patients with CAP were administered 500 mg of nemonoxacin orally once daily for 8.24 ± 3.73 days. Fourteen patients were lost during the follow-up period. At the end of the follow-up period, information on 323 patients (132 males and 191 females) with a median age of 52 (P25, P75: 34, 61) years was collected. On the basis of CRB-65 scores, 273 and 50 cases were classified to have low and intermediate risks, respectively. After 3 days of treatment, the symptom improvement rate was 61.3% (198 patients). Improved symptoms or cures were evident in 98.14% (317 patients) of the patients after treatment was completed. Five (1.55%) patients were hospitalized for poor treatment efficacy, and one (0.31%) patient was diagnosed with lung cancer ...Continue Reading

References

May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kelly E DooleyTimothy R Sterling
Mar 20, 2009·Seminars in Respiratory and Critical Care Medicine·Tobias Welte, Thomas Köhnlein
Sep 10, 2009·Antimicrobial Agents and Chemotherapy·Heather J AdamGeorge G Zhanel
Jul 28, 2010·Antimicrobial Agents and Chemotherapy·Dirkie J J van RensburgMing-Chu Hsu
Jan 26, 2011·Antimicrobial Agents and Chemotherapy·Yi-Chun LinPo-Ren Hsueh
Mar 4, 2014·Expert Review of Anti-infective Therapy·Chung-Chih LaiPo-Ren Hsueh
Jul 22, 2014·Drug Design, Development and Therapy·Xiaohua Qin, Haihui Huang
Jun 9, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Siddhartha RoychoudhuryMing Chu Hsu
Feb 2, 2019·Intensive Care Medicine·Antoni TorresRichard G Wunderink
Mar 6, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Márió Gajdács
Feb 23, 2020·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Khalid EljaalyMohannad Alshibani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Drug Design, Development and Therapy
Xiaohua Qin, Haihui Huang
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
W P HuJ M Qu
Expert Opinion on Pharmacotherapy
Chung-Hao HuangPo-Ren Hsueh
© 2021 Meta ULC. All rights reserved